WHO position statement on the use of delamanid for multidrug-resistant tuberculosis : Expedited review of the phase III clinical trial data of delamanid added to an optimised background MDR-TB regimen / World Health Organization; Moja L. ; [a cura di] W. Health Organization, L. Moja. - [s.l] : World Health Organization, 2018 Jan.
WHO position statement on the use of delamanid for multidrug-resistant tuberculosis : Expedited review of the phase III clinical trial data of delamanid added to an optimised background MDR-TB regimen
L. Moja
2018
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
WHOPositionStatementDelamanidUse.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
592.68 kB
Formato
Adobe PDF
|
592.68 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
